Self-Testing Market Report 2026

The self-testing market size has grown rapidly in recent years. It will grow from $16.88 billion in 2025 to $18.61 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing awareness of early disease detection, technological advances in diagnostics, home-based testing adoption, expansion of chronic disease monitoring, regulatory approvals for OTC tests.

The self-testing market size is expected to see strong growth in the next few years. It will grow to $25.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to AI-integrated test interpretation, smartphone-compatible diagnostics, expansion in infectious disease self-tests, telemedicine-linked testing, personalized testing solutions. Major trends in the forecast period include rapid diagnostic kits, AI-powered test analysis, at-home lab testing, mobile-connected health tests, disease-specific test kits.

The rising prevalence of chronic diseases is expected to drive the growth of the self-testing market in the coming years. Chronic diseases are long-term medical conditions that typically develop slowly and persist over an extended period. Their increasing incidence is influenced by demographic shifts, lifestyle habits, environmental factors, and advancements in healthcare. Self-testing is used by individuals with chronic conditions to actively manage their health, improve adherence to treatment plans, and facilitate early detection of any complications or changes in their condition. For example, in April 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported that in 2023, approximately 76.4% of U.S. adults had at least one of 12 selected chronic conditions, with 51.4% reporting multiple chronic conditions. Therefore, the growing prevalence of chronic diseases is fueling the expansion of the self-testing market.

Key companies in the self-testing market are focusing on developing innovative solutions, such as Cervicheck self-sampling kits, to provide users with greater convenience, accessibility, and accuracy. These medical devices allow individuals to collect biological samples, including blood, saliva, urine, or tissue, for diagnostic testing or analysis. For instance, in April 2023, Pragmatech Healthcare Solutions, an India-based biotechnology company, launched Cervicheck, a self-testing kit for screening women for human papillomavirus (HPV), a major cause of cervical cancer. The kit enables women to collect samples in the privacy of their homes, addressing delays in detection due to reluctance to undergo sample collection at hospitals or clinics. It features self-sampling and point-of-care detection, representing an important step in empowering women to detect cervical cancer early and reduce mortality rates and the burden associated with late-stage diagnosis.

In December 2024, OraSure Technologies Inc., a US-based provider of point-of-need and home diagnostic tests and sample collection devices, acquired Sherlock Biosciences Inc. for an undisclosed amount. Through this acquisition, OraSure aims to expand its molecular diagnostics pipeline and accelerate the development of over-the-counter, high-accuracy self-tests by leveraging Sherlock’s advanced isothermal amplification and CRISPR-based molecular platform. Sherlock Biosciences, a US-based biotechnology company, develops rapid, next-generation molecular diagnostics suitable for self-collected samples, including self-tests for Chlamydia and Gonorrhea.

Major companies operating in the self-testing market are Roche Diagnostics, Abbott Laboratories, Quidel Corporation, OraSure Technologies, Meridian Bioscience, iHealth Labs, Everly Health, Helix OpCo, BioIQ, 23andMe, Pathway Genomics, Vitagene, Orig3n, LetsGetChecked, Cue Health, Ellume Health, OraQuick, Atomo Diagnostics, ACON Laboratories, SD Biosensor, OraSure Diagnostics.

North America was the largest region in the self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the self-testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have created both challenges and adjustments in the self-testing market by increasing the cost of imported test kits, diagnostic strips, biosensors, and electronic testing devices. Countries in Asia-Pacific and Latin America that depend on imported glucose meters, pregnancy test devices, and COVID-19 or HIV test kits have experienced higher retail prices and supply delays. These cost pressures can limit accessibility for home-based testing, particularly in price-sensitive populations. However, tariffs are encouraging local manufacturing of diagnostic kits and devices, which is improving supply chain stability and supporting long-term growth in the self-testing market.

The self-testing market research report is one of a series of new reports that provides self-testing market statistics, including self-testing industry global market size, regional shares, competitors with a self-testing market share, detailed self-testing market segments, market trends and opportunities, and any further data you may need to thrive in the self-testing industry. This self-testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Self-testing refers to the practice in which individuals use diagnostic tools or kits to test themselves for specific medical conditions or characteristics without the direct supervision of a healthcare professional. These tests enable people to monitor their health, screen for particular conditions, or manage chronic diseases at home, providing advantages such as convenience, privacy, and patient empowerment.

The main product types in self-testing include kits, devices, and strips. Kits are complete packages containing all the materials and instructions needed for individuals to collect and analyze their own samples. They can be used with various sample types, including blood, urine, stool, and others, and are available through multiple distribution channels, both online and offline. These kits are applied for a wide range of purposes, including blood glucose monitoring, pregnancy and fertility testing, cancer screening, drug abuse detection, testing for sexually transmitted diseases or infections, cholesterol measurement, HIV testing, thyroid testing, and more.

The self-testing market consist of revenues earned by entities by providing services such as medical self-testing services, professional skills self-assessment services, medical stimulation services, and fitness and wellness self-testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The self-testing market also includes sales of medical self-testing products, health monitoring wearables, online symptom checkers, home diagnostic kits, personal health monitoring devices, and disease-specific testing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.